Welcome to Phil Erlanger Research

  SEPR: 48.66% gain
  AAPL: 17.15% gain
  BVF: _ 50.85% gain

The above symbols are examples of recent long and short "squeeze" recomendations made to our clients. Click on any one of them for details.

 

Welcome to ErlangerResearch.com, a resource for investors seeking advanced technical analysis research and data. State-of-the-art computational techniques are combined with important, proprietary market data, enabling Phil Erlanger Research to offer independent, value-added data and analysis on over 6000 equity issues, 139 industry groups and 18 sectors. Following his experience as Advest 's Chief Technical Analyst, and his 5 year tenure as Senior Technical Analyst for Fidelity Management & Research Co. , Inc., Philip B. Erlanger formed his own company with the goal of providing high quality, unique information and research of its kind by offering:

  • Unique data series (such as normalized data on short selling activity, and on trading in equity options).
  • Advanced, yet easily understood measurements of the technical attractiveness of stocks, groups and sectors.
  • An effective format for incorporating Erlanger information into our client's investment decision process through the use of our Erlanger Power Portfolio and Erlanger 2000 software products.

Company highlights

  • Since Phil Erlanger Research began in 1994, client hedge fund assets have grown from $150 billion to $800 billion and are expected to grow to $1 trillion by 2006. You need someone in your corner watching how the hedge funds move in and out of short positions. Additionally, we track unusual movements in the options market.
  • The Short and  Long Squeeze Screens have returned 136.21% since March 15, 2002 through November 19, 2004. The S&P 500 is up only  7.13%, Fidelity Magellan is down -0.15% and American Funds Investment Company of America Class A share  is up 12.98% during the same period. Follow these screens and know when to own stocks and when to short them.

 

 

 

 

 

Warranties, Disclaimers & Legal Rights || Risk Disclosure || Earnings Disclaimer
Terms of Service || Privacy Policy